Aspirin Dose Recommendations for Stroke Prevention

Introduction to Aspirin Therapy

The American Heart Association recommends aspirin 75-100 mg daily for stroke prevention, balancing efficacy with safety across both primary and secondary prevention settings 1, 2

Patients with prior ischemic stroke or transient ischemic attack (TIA) should receive aspirin 75-100 mg daily for long-term secondary prevention, providing equivalent stroke risk reduction compared to higher doses while minimizing bleeding complications 3, 4, 5
For minor ischemic stroke or high-risk TIA, consider dual antiplatelet therapy with aspirin 81 mg daily plus clopidogrel 75 mg daily for 21 days, then transition to single antiplatelet therapy 6
For patients with mechanical prosthetic heart valves who experience stroke despite adequate anticoagulation, add aspirin 75-100 mg daily to warfarin (INR 2.5-3.5) if bleeding risk is acceptable 3, 4, 5, 7

For primary stroke prevention in high-risk individuals, aspirin 75-100 mg daily is recommended when cardiovascular risk is sufficiently elevated to outweigh bleeding risks 1, 2, 8
The American College of Cardiology recommends aspirin therapy for women ≥65 years with controlled blood pressure and 10-year cardiovascular risk >6-10% 2, 6
Patients with high-risk antiphospholipid profile or systemic lupus erythematosus and high-risk antiphospholipid profile may benefit from aspirin therapy 1
Diabetic patients ≥50 years with hypertension plus at least one additional major cardiovascular risk factor may also benefit from aspirin therapy 2

Before initiating aspirin, assess for contraindications and high bleeding risk, including absolute contraindications such as active gastrointestinal bleeding, documented aspirin allergy, bleeding disorders, and clinically active hepatic disease 2
High bleeding risk factors include age >70 years, uncontrolled hypertension, concomitant NSAIDs or anticoagulants, and history of gastrointestinal bleeding 2, 8
Expected bleeding rates with aspirin therapy are approximately 2-4 per 1,000 middle-aged persons (4-12 per 1,000 older persons) over 5 years 2

For patients with documented aspirin allergy requiring antiplatelet therapy, substitute clopidogrel 75 mg daily 2, 8

Elderly patients on aspirin should be evaluated for occult gastrointestinal bleeding that could contribute to electrolyte imbalances through chronic blood loss, and checked for hemoglobin/hematocrit and stool guaiac to rule out bleeding, according to the American Heart Association 9
Obtain comprehensive metabolic panel to assess current electrolyte status given history of imbalances, and ensure adequate hydration to maintain normovolemia, avoiding glucose-containing solutions, as recommended by the American Stroke Association 9
Common electrolyte disturbances in elderly patients on aspirin include hyponatremia, hypokalemia, and dehydration, which can be monitored and prevented with proper management, as suggested by the American Heart Association 10

Aggressive blood pressure control is essential in patients with lacunar stroke history, with a target blood pressure of <140/90 mmHg, or <130/80 mmHg if tolerated, as recommended by the American Heart Association 11
Consider ACE inhibitor or angiotensin receptor blocker therapy to reduce cardiovascular event risk, according to the American Diabetes Association 12

Age >60 years is a significant risk factor for aspirin-related bleeding, and major bleeding occurs at approximately 5 per 1,000 per year in real-world settings with aspirin, as reported by the American Diabetes Association 12
Contraindications to continued aspirin include bleeding disorders, which should be assessed and monitored regularly, as recommended by the American Diabetes Association 12